Product
Influenza Virus Vaccine, Monovalent A/H3N2v A/Minnesota/11/2010 NYMC X-203
1 clinical trial
3 indications
Indication
Avian InfluenzaIndication
Influenza A virus subtype H1N1Indication
InfluenzaClinical trial
A Phase II Study to Evaluate and Compare the Immunogenicity of Monovalent Inactivated Influenza A/H7N9 Virus Vaccine Administered With and Without AS03 Adjuvant and Monovalent Inactivated Influenza A/H3N2v Virus Vaccine Administered Without Adjuvant in Healthy Adults Through Standard and Systems Biology AnalysesStatus: Completed, Estimated PCD: 2017-03-28